Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited

Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited

HONG KONG, Jan. 11, 2025 /PRNewswire/ -- Dunxin Financial Holdings ("DXF" or the "Company") (OTC Pink: DXFFY, DXFFD) is pleased to announce that effective on January 10, 2025, the Company will change its name to "Eason Technology Limited" and its...

Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases

Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...

Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress

Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress

Announces Major Milestones at the JPM Healthcare Conference SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded as Xylo Bio. This transformation reflects the company's...

Argon Medical Announces First Patient Enrollment in CLEAN-PE, a Prospective, Multicenter Study of a New Treatment for Pulmonary Embolism

Argon Medical Announces First Patient Enrollment in CLEAN-PE, a Prospective, Multicenter Study of a New Treatment for Pulmonary Embolism

PLANO, Texas, Jan. 9, 2025 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the first patient enrollment in...

Acer Announces Preliminary Full Year 2024 Revenues at NT$264.71 Billion, Up 9.7% YoY, with Businesses Other Than PCs and Displays Contributing 28.3% of Total Revenues

Acer Announces Preliminary Full Year 2024 Revenues at NT$264.71 Billion, Up 9.7% YoY, with Businesses Other Than PCs and Displays Contributing 28.3% of Total Revenues

Q4'24 preliminary consolidated revenues at NT$66.12 billion, up 4.7% YoY, showing six consecutive quarters of YoY growth TAIPEI, Jan. 9, 2025 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its preliminary consolidated revenues for full year 2024...

Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency

Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency

FRANKFURT, Germany, Jan. 9, 2025 /PRNewswire/ -- Anbio Biotechnology ("Anbio"), a global leader in diagnostics innovation, announces the launch of its Dry Chemiluminescence Immunoassay (CLIA) Solution ADL-1000, a transformative technology designed...

YEEDI S14 PLUS Wins Indoor Cleaning Technology Innovation Gold Award: Redefining Home Cleaning with Excellence in Innovation

YEEDI S14 PLUS Wins Indoor Cleaning Technology Innovation Gold Award: Redefining Home Cleaning with Excellence in Innovation

LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- YEEDI, a trailblazer in intelligent cleaning solutions, proudly announces that its latest product, YEEDI S14 PLUS, has been awarded the Indoor Cleaning Technology Innovation Gold Award by Global Top Brands...

TCTM Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price

TCTM Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price

BEIJING, Jan. 9, 2025 /PRNewswire/ -- TCTM Kids IT Education Inc. (NASDAQ: TCTM) ("TCTM" or the "Company"), a leading provider of IT-focused supplementary STEM education services in China, today announced that it received a written notification from...

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

CAMBRIDGE, England and SAN DIEGO, Jan. 9, 2025 /PRNewswire/ -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated by its "First in Human"...

Vidnoz Achieves ISO/IEC 27001:2022 Certification for Information Security Management

Vidnoz Achieves ISO/IEC 27001:2022 Certification for Information Security Management

SAN FRANCISCO, Jan. 9, 2025 /PRNewswire/ -- Vidnoz, an innovative AI tool platform, proudly announces its successful ISO/IEC 27001:2022 certification. This certification reflects Vidnoz's strong commitment to information security, enhancing the...

  • 1
  • ...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • ...
  • 34
  • menu
    menu